Estados Unidos · Plataformas y datos · The Motley Fool

Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?

Publicado por The Motley Fool · Estados Unidos hace 37 min

Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy? — Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy? · The Motley Fool

Resumen detallado

These healthcare dividend stocks appeal to investors in different ways.

Leer el artículo completo en The Motley Fool Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com)

También te puede interesar

Microsoft services fully restored after outage

Bernicke Wealth Management Ltd. Makes New Investment in Intel Corporation $INTC

Cloudastructure founder Bentley sells $2,370 in shares

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

Prediction: Nov. 18 Will Be a Massive Day for the Stock Market

Jensen Huang Misled Nvidia Leadership, Lawyer On Affair With Alleged Chinese Spy: Report